| Document Date: 2011-09-23 12:47:19
Open Document File Size: 383,55 KBShare Result on Facebook
Company Gilead Sciences Inc. / Bristol-Myers Squibb LLC / / Facility Laboratory Abnormalities / / IndustryTerm hepatitis B therapy / machinery / treatment of HIV / fixed-dose combination product / combination product / / MedicalCondition inflammatory response / neural tube defects / DF / Fanconi syndrome / severe hypophosphatemia / mild-to-moderate rash / fetal resorptions / HIV / headache / HBV / seizures / liver failure / rash resolves / renal tubular injury / Convulsions Convulsions / hallucinations / dysfunction / nausea / skin rash / hepatitis B / Stevens-Johnson syndrome / fatigue / drowsiness / Obesity / erythema multiforme / residual opportunistic infections / clinically significant hypersensitivity / hypersensitivity / diarrhea / Hypersensitivity ATRIPLA / liver disease / Steatosis Lactic acidosis / Birth defects / hepatic disease / Immune reconstitution syndrome / osteopenia / insomnia / Convulsions / Immune Reconstitution Syndrome Immune reconstitution syndrome / meningomyelocele / neural tube defect / amnesia / Carcinogenesis / cardiac arrhythmias / chronic HBV infection / unilateral anophthalmia / pre-existing hepatic disease / C infection / fever / stupor / LACTIC ACIDOSIS / cleft palate / severe rash / severe depression / hepatic failure / pancreatitis / osteomalacia / respiratory depression / infection / dizziness / depression / Rash / chronic hepatitis B / Anencephaly / acute renal failure / anophthalmia / / MedicalTreatment antiretroviral treatment / antiretroviral therapy / contraception / Barrier contraception / / Organization FDA / / / Position General Information 5.13 Immune Reconstitution Syndrome / / Product Combivir / efavirenz / EMTRIVA / zidovudine / Trizivir / abacavir sulfate / SUSTIVA / TRUVADA / vitamin D / HEPSERA / triazolam / Epivir / Epzicom / Epivir-HBV / tenofovir disoproxil fumarate / phenytoin / nevirapine / lamivudine / VIREAD / Didanosine / ATRIPLA / Name Clinical Comment Antifungal / stavudine / / PublishedMedium Microbiology / / Technology Pharmacokinetics / / URL www.fda.gov/medwatch / /
SocialTag |
serum phosphorus in patients at risk. Avoid administering ATRIPLA with concurrent or recent use of nephrotoxic drugs[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed